This inventor holds 2 USPTO granted patents. Top assignee: St. Jude Children's Research Hospital. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Innovative Contributions of Karim C El Kasmi in Pneumococcal Infection Treatment
Introduction: Karim C El Kasmi, based in Denver, CO, is a distinguished inventor whose contributions to medical research are underscored by his two patents. His work primarily focuses on developing compositions and methods aimed at preventing and treating pneumococcal infections, a significant public health concern.
Latest Patents: El Kasmi's latest patents detail innovative compositions that include novel polypeptides featuring specific amino acid sequences corresponding to the R2 and R22 domains of CbpA. These sequences are designed to stabilize the polypeptide in a desired conformation, particularly a loop conformation. The strategic engineering of these polypeptides to include cysteine residues enables the formation of disulfide bonds, further enhancing stability. Additionally, his inventions encompass nucleic acid molecules encoding these polypeptides, which open avenues for the development of immunogenic compositions and vaccines, emphasizing their potential utility in clinical settings.
Career Highlights: Karim C El Kasmi currently operates within the esteemed St. Jude Children's Research Hospital, where he applies his expertise in biotechnology to combat infectious diseases. His role involves collaboration with a talented team of researchers and fellow inventors.
Collaborations: Throughout his career, El Kasmi has worked alongside notable colleagues such as Brad Jordan and Richard Kriwacki. Their collective efforts enable advancements in their field, fostering a collaborative environment that promotes innovative research and development.
Conclusion: Karim C El Kasmi's work exemplifies the vital intersection of innovation and healthcare. His patents not only advance our understanding of pneumococcal infections but also highlight the importance of collaboration in achieving significant medical breakthroughs. His contributions continue to shape the future of treatment methods, benefiting countless individuals in the fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile